{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:45:02Z","timestamp":1792763102514,"version":"4.5.0"},"reference-count":30,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2021,2,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Fabry Disease (FD, OMIM#301500) is a progressive, life-threatening, multisystemic,\nrare lysosomal storage disease. Today, approximately 1000 mutations are recorded in the\nHuman Gene Mutation Database (www.hgmd.org) for GLA. Among the identified mutations, genetic\nvariants of unknown significance (GVUS) and novel mutations cause problems in terms of diagnosis\nand treatment approach.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In our study, 510 high-risk patients were enrolled. 229 out of 510 were Male (45%) (Mean\nage was 40.8 \u00b115.0) and 281 of were Female (55%) (Mean age was 39, 7\u00b115.5). The definite diagnosis\nof the FD was confirmed by GLA gene sequence analysis. GLA mutation was found in 15 cases\n(3.4%). Family members of the relevant indexes were included in the screening programs according to\nthe X-linked inheritance pattern. And then we conducted family screening on 74 family members of 15\nindex cases. Of those 74 cases, 39 had mutations (53%). In males, \u03b1-GalA activity and in both gender\nLyso-Gb3 levels were measured and multisystem evaluation was performed in all cases with the mutation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>We found six different familial mutation types; two of them pathogenic; p.D170N (1),\np.P205S (13), one of them GVUS; p.Q330R (1), three of them likely benign; p.D313Y (12), p.S126G\n(25), c.-30G&gt;A (2) mutations were detected.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>The purpose of this retrospective study is to approach Fabry disease on a genetic basis\nand to improve its management and to draw attention to the importance of early diagnosis. We also\naimed to evaluate the appropriate algorithms to determine whether the mutation is the FD-causing mutation\nor not.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530320666200708135826","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T07:16:00Z","timestamp":1594278960000},"page":"324-337","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genetic Management Algorithm in High-Risk Fabry Disease Cases; Especially in Female Indexes with Mutations"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5727-7965","authenticated-orcid":true,"given":"Ozlem","family":"Sezer","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, Samsun Training and Research Hospital, Samsun,Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2786-1911","authenticated-orcid":true,"given":"Serdar","family":"Ceylaner","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Intergen Genetic Centre, Ankara,Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.kint.2016.10.004","volume":"91","author":"Schiffmann R.","year":"2017","unstructured":"Schiffmann R.; Hughes D.A.; Linthorst G.E.; Ortiz A.; Svarstad E.; Warnock D.G.; West M.L.; Wanner C.; Screening, diagnosis, and management of patients with Fabry disease: conclusions from a \u201cKidney disease: improving global outcomes\u201d (KDIGO) controversies conference. Kidney Int 2017,91(2),284-293","journal-title":"Kidney Int"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"200.e1","DOI":"10.1016\/j.amjmed.2017.09.010","volume":"131","author":"Maron M.S.","year":"2018","unstructured":"Maron M.S.; Xin W.; Sims K.B.; Butler R.; Haas T.S.; Rowin E.J.; Desnick R.J.; Maron B.J.; Identification of Fabry disease in a tertiary referral cohort of patients with hypertrophic cardiomyopathy. Am J Med 2018,131(2),200.e1-200.e8","journal-title":"Am J Med"},{"key":"ref=3","first-page":"139","volume":"3","author":"Capuano I.","year":"2019","unstructured":"Capuano I.; Garofalo C.; Buonanno P.; Pinelli M.; Di Risi T.; Feriozzi S.; Riccio E.; Pisani A.; Identifying Fabry patients in dialysis population: prevalence of gla mutations by renal clinic screening, 1995\u20132019. J Nephrol 2019,3(1),139-145","journal-title":"J Nephrol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1161\/STROKEAHA.112.663708","volume":"44","author":"Rolfs A.","year":"2013","unstructured":"Rolfs A.; Fazekas F.; Grittner U.; Dichgans M.; Martus P.; Holzhausen M.; B\u00f6ttcher T.; Heuschmann P.U.; Tatlisumak T.; Tanislav C.; Jungehulsing G.J.; Giese A.K.; Putaala J.; Huber R.; Bodechtel U.; Lichy C.; Enzinger C.; Schmidt R.; Hennerici M.G.; Kaps M.; Kessler C.; Lackner K.; Paschke E.; Meyer W.; Mascher H.; Riess O.; Kolodny E.; Norrving B.; Acute cerebrovascular disease in the young: the stroke in young Fabry patients study. Stroke 2013,44(2),340-349","journal-title":"Stroke"},{"key":"ref=5","author":"Desnick R.J.","year":"2014","unstructured":"Desnick R.J.; Ioannou Y.A.; Eng C.M.; \u03b1-Galactosidase a deficiency: Fabry disease. The Online Metabolic and Molecular Bases of Inherited Disease; David, Valle, Ed.; McGraw-Hill Med.: New York 2014"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2016090964","volume":"28","author":"Arends M.","year":"2017","unstructured":"Arends M.; Wanner C.; Hughes D.; Mehta A.; Oder D.; Watkinson O.T.; Elliott P.M.; Linthorst G.E.; Wijburg F.A.; Biegstraaten M.; Hollak C.E.; Characterization of classical and nonclassical Fabry disease: a multicenter study. J Am Soc Nephrol 2017,28(5),1631-1641","journal-title":"J Am Soc Nephrol"},{"key":"ref=7","unstructured":"The Human Gene Mutation DatabaseAvailable from:"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10897-013-9613-3","volume":"22","author":"Laney D.A.","year":"2013","unstructured":"Laney D.A.; Bennett R.L.; Clarke V.; Fox A.; Hopkin R.J.; Johnson J.; O\u2019Rourke E.; Sims K.; Walter G.; Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors. J Genet Couns 2013,22(5),555-564","journal-title":"J Genet Couns"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10897-007-9128-x","volume":"17","author":"Laney D.A.","year":"2008","unstructured":"Laney D.A.; Fernhoff P.M.; Diagnosis of Fabry disease via analysis of family history. J Genet Couns 2008,17(1),79-83","journal-title":"J Genet Couns"},{"key":"ref=10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003632","volume":"9","author":"Lukas J.","year":"2013","unstructured":"Lukas J.; Giese A.K.; Markoff A.; Grittner U.; Kolodny E.; Mascher H.; Lackner K.J.; Meyer W.; Wree P.; Saviouk V.; Rolfs A.; Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease. PLoS Genet 2013,9(8)","journal-title":"PLoS Genet"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","volume":"308","author":"Chamoles N.A.","year":"2001","unstructured":"Chamoles N.A.; Blanco M.; Gaggioli D.; Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin Chim Acta [4]2001,308(1-2),195-196","journal-title":"Clin Chim Acta"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1515\/cclm-2016-0340","volume":"55","author":"Polo G.","year":"2017","unstructured":"Polo G.; Burlina A.P.; Kolamunnage T.B.; Zampieri M.; Dionisi-Vici C.; Strisciuglio P.; Zaninotto M.; Plebani M.; Burlina A.B.; Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS\/MS. Clin Chem Lab Med 2017,55(3),403-414","journal-title":"Clin Chem Lab Med"},{"key":"ref=13","unstructured":"ClinVar DatabaseAvailable from:"},{"key":"ref=14","unstructured":"The Fabry disease mutation database.Available from:"},{"key":"ref=15","unstructured":"International Fabry Disease Genotype-Phenotype Database (dbFGP). Available from:"},{"key":"ref=16","unstructured":"CentogeneAvailable from:"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","volume":"123","author":"Ortiz A.","year":"2018","unstructured":"Ortiz A.; Germain D.P.; Desnick R.J.; Politei J.; Mauer M.; Burlina A.; Eng C.; Hopkin R.J.; Laney D.; Linhart A.; Waldek S.; Wallace E.; Weidemann F.; Wilcox W.R.; Fabry disease revisited: Management and treatment recommendations for adult patients. Mol Genet Metab 2018,123(4),416-427","journal-title":"Mol Genet Metab"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/8904_2015_424","volume":"23","author":"Ferreira S.","year":"2015","unstructured":"Ferreira S.; Reguenga C.; Oliveira J.P.; The Modulatory Effects of the Polymorphisms in GLA 5\u2032-Untranslated Region Upon Gene Expression Are Cell-Type Specific. JIMD Rep 2015,23,27-34","journal-title":"JIMD Rep"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ymgme.2017.07.002","volume":"123","author":"Nowak A.","year":"2018","unstructured":"Nowak A.; Mechtler T.P.; Hornemann T.; Gawinecka J.; Theswet E.; Hilz M.J.; Kasper D.C.; Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease. Mol Genet Metab 2018,123(2),148-153","journal-title":"Mol Genet Metab"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.3390\/ijms19123726","volume":"19","author":"Duro G.","year":"2018","unstructured":"Duro G.; Zizzo C.; Cammarata G.; Burlina A.; Burlina A.; Polo G.; Scalia S.; Oliveri R.; Sciarrino S.; Francofonte D.; Alessandro R.; Pisani A.; Palladino G.; Napoletano R.; Tenuta M.; Masarone D.; Limongelli G.; Riccio E.; Frustaci A.; Chimenti C.; Ferri C.; Pieruzzi F.; Pieroni M.; Spada M.; Castana C.; Caserta M.; Monte I.; Rodolico M.S.; Feriozzi S.; Battaglia Y.; Amico L.; Losi M.A.; Autore C.; Lombardi M.; Zoccali C.; Testa A.; Postorino M.; Mignani R.; Zachara E.; Giordano A.; Colomba P.; Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? Int J Mol Sci 2018,19(12),3726","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/humu.10275","volume":"22","author":"Yasuda M.","year":"2003","unstructured":"Yasuda M.; Shabbeer J.; Benson S.D.; Maire I.; Burnett R.M.; Desnick R.J.; Fabry disease: characterization of \u03b1-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele. Hum Mutat 2003,22(6),486-492","journal-title":"Hum Mutat"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/STROKEAHA.109.570499","volume":"41","author":"Baptista M.V.","year":"2010","unstructured":"Baptista M.V.; Ferreira S.; Pinho-E-Melo, T.; Carvalho, M.; Cruz, V.T.; Carmona, C.; Silva, F.A.; Tuna, A.; Rodrigues, M.; Ferreira, C.; Pinto, A.A.; Leit\u00e3o, A.; Gabriel, J.P.; Calado, S.; Oliveira, J.P.; Ferro, J.M. Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study--screening genetic conditions in Portuguese young stroke patients. Stroke 2010,41(3),431-436","journal-title":"Stroke"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/STROKEAHA.110.579409","volume":"41","author":"Brouns R.","year":"2010","unstructured":"Brouns R.; Thijs V.; Eyskens F.; Van den Broeck M.; Belachew S.; Van Broeckhoven C.; Redondo P.; Hemelsoet D.; Fumal A.; Jeangette S.; Verslegers W.; Baker R.; Hughes D.; De Deyn P.P.; Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease. Stroke 2010,41(5),863-868","journal-title":"Stroke"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055565","volume":"8","author":"Lenders M.","year":"2013","unstructured":"Lenders M.; Duning T.; Schelleckes M.; Schmitz B.; Stander S.; Rolfs A.; Brand S.M.; Brand E.; Multifocal white matter lesions associated with the D313Y mutation of the \u03b1-galactosidase A gene. PLoS One 2013,8(2)","journal-title":"PLoS One"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/0886022X.2016.1254656","volume":"39","author":"Yeni\u00e7erio\u011flu Y.","year":"2017","unstructured":"Yeni\u00e7erio\u011flu Y.; Akdam H.; Dursun B.; Alp A.; Sa\u011flam Eyiler F.; Ak\u0131n D.; G\u00fcn Y.; H\u00fcddam B.; Batmazo\u011flu M.; Gibyeli Genek D.; Pirin\u00e7\u00e7i S.; Ersoy \u0130.R.; \u00dcz\u00fcm A.; Soypa\u00e7ac\u0131 Z.; Tanr\u0131sev M.; \u00c7olak H.; Demiral Sezer S.; Bozkurt G.; Aky\u0131ld\u0131z U.O.; Aky\u00fcz \u00dcnsal A.\u0130.; \u00dcn\u00fcbol M.; Uslu M.; Ery\u0131lmaz U.; G\u00fcnel C.; Meteo\u011flu \u0130.; Yava\u015fo\u011flu \u0130.; \u00dcnsal A.; Akar H.; Okyay P.; Screening Fabry\u2019s disease in chronic kidney disease patients not on dialysis: a multicenter study. Ren Fail 2017,39(1),104-111","journal-title":"Ren Fail"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017098","volume":"7","author":"Koulousios K.","year":"2017","unstructured":"Koulousios K.; Stylianou K.; Pateinakis P.; Zamanakou M.; Loules G.; Manou E.; Kyriklidou P.; Katsinas C.; Ouzouni A.; Kyriazis J.; Speletas M.; Germenis A.E.; Fabry disease due to D313Y and novel GLA mutations. BMJ Open 2017,7(10)","journal-title":"BMJ Open"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2350-11-19","volume":"11","author":"Gaspar P.","year":"2010","unstructured":"Gaspar P.; Herrera J.; Rodrigues D.; Cerezo S.; Delgado R.; Andrade C.F.; Forascepi R.; Macias J.; del Pino M.D.; Prados M.D.; de Alegria P.R.; Torres G.; Vidau P.; S\u00e1-Miranda M.C.; Frequency of Fabry disease in male and female haemodialysis patients in Spain. BMC Med Genet 2010,11,19","journal-title":"BMC Med Genet"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jacc.2016.05.090","volume":"68","author":"Favalli V.","year":"2016","unstructured":"Favalli V.; Disabella E.; Molinaro M.; Tagliani M.; Scarabotto A.; Serio A.; Grasso M.; Narula N.; Giorgianni C.; Caspani C.; Concardi M.; Agozzino M.; Giordano C.; Smirnova A.; Kodama T.; Giuliani L.; Antoniazzi E.; Borroni R.G.; Vassallo C.; Mangione F.; Scelsi L.; Ghio S.; Pellegrini C.; Zedde M.; Fancellu L.; Sechi G.; Ganau A.; Piga S.; Colucci A.; Concolino D.; Di Mascio M.T.; Toni D.; Diomedi M.; Rapezzi C.; Biagini E.; Marini M.; Rasura M.; Melis M.; Nucera A.; Guidetti D.; Mancuso M.; Scoditti U.; Cassini P.; Narula J.; Tavazzi L.; Arbustini E.; Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics. J Am Coll Cardiol 2016,68(10),1037-1050","journal-title":"J Am Coll Cardiol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/jmedgenet-2017-104863","volume":"55","author":"Arends M.","year":"2018","unstructured":"Arends M.; Biegstraaten M.; Wanner C.; Sirrs S.; Mehta A.; Elliott P.M.; Oder D.; Watkinson O.T.; Bichet D.G.; Khan A.; Iwanochko M.; Vaz F.M.; van Kuilenburg A.B.P.; West M.L.; Hughes D.A.; Hollak C.E.M.; Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study. J Med Genet 2018,55(5),351-358","journal-title":"J Med Genet"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/humu.22910","volume":"37","author":"Lukas J.","year":"2016","unstructured":"Lukas J.; Scalia S.; Eichler S.; Pockrandt A.M.; Dehn N.; Cozma C.; Giese A.K.; Rolfs A.; Functional and Clinical Consequences of Novel \u03b1-Galactosidase A Mutations in Fabry Disease. Hum Mutat 2016,37(1),43-51","journal-title":"Hum Mutat"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/183568","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.eurekaselect.com\/183568\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/eurekaselect.com\/article\/download\/183568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,2]],"date-time":"2022-01-02T14:51:32Z","timestamp":1641135092000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/183568\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530320666200708135826","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}